DNAiTECH Ltd software

DNAiTECH is advancing the field of in-field and point-of-care diagnostics with the development of innovative testing instruments. Their Gen3 platform, slated for release in 2024, aims to meet the World Health Organization`s ASSURED criteria, encompassing affordability, sensitivity, user-friendliness, and robustness, among other factors. This platform incorporates microfluidics and LAMP-CRISPR diagnostics, making it a sophisticated tool for rapid molecular diagnostics outside of conventional laboratory settings. Furthermore, in-field testing using isothermal amplification methods lowers instrumentation energy demands and simplifies DNA analysis, vital for environments with limited infrastructure. DNAiTECH`s technology holds promise for enhancing diagnostic capabilities in medical, environmental, and agricultural sectors, balancing high technical specifications with the need for accessibility in resource-constrained settings.